SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys more than $1.3 billion, three-year agreement to supply engines, license propulsion technology and provide engineering support to AST SpaceMobile is driving attention and a sharp share-price jump. Many traders view the deal as validation of Fireflys engine business and a major backlog boost, while others question the payment terms, potential dilution and whether the rally can hold ahead of earnings.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POETs sharp rebound after a steep photonics-sector selloff is being discussed alongside Foxconn Tech Day evidence of POET optical hardware in Foxconns ecosystem, which bulls view as validation of its AI data-center opportunity. Skeptics note that a product display or design relationship does not confirm purchase orders, scaled shipments, or revenue, and are looking to upcoming results for proof of commercialization.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs pending decision on Capricors Duchenne muscular dystrophy therapy deramiocel, with traders weighing HOPE-3 upper-limb data and a letter from treating specialists against concerns about the FDA review and the risk of a rejection. The debate is fueling bullish approval expectations and speculative talk of a short squeeze, alongside warnings that the outcome remains uncertain.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Positive Phase 3 DAYBREAK results for Kodiaks retinal-disease programs, alongside reported Baker Brothers share purchases, have fueled the stocks sharp run. Traders are split between optimism about the pipeline and institutional backing and concerns over valuation, cash needs, and possible dilution.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Speculation around the federal cannabis Schedule III process, including the ALJ recommendation and potential 280E tax relief, is the dominant topic. Bullish traders point to Green Thumbs balance sheet, buybacks and recent results, while others question its margins and lagging share performance and remain wary of regulatory delays.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gileads quarterly results beat expectations and the company raised its full-year product-sales outlook, with traders pointing to strength in its HIV franchise and growing prevention-drug demand. The reaction is broadly positive, though some remain cautious about acquisition-related accounting costs and put-heavy options activity.

Cornerstone Strategic Value Fund is a management investment company that is an investment operation. They limit the fund's investment in securities issued by other investment companies.

Cornerstone Strategic Investment Fund Inc.

Cornerstone Strategic Investment Fund, Inc.

CLMs annual distribution reset is driving discussion, with traders weighing the lower 2027 payout against the funds high-yield strategy. Debate also centers on rights-offering uncertainty and the shares trading near or below NAV: some see a buying opportunity, while others worry about dilution, further price erosion, and a possible reverse split.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Foxs acquisition of Roku and the end of Rokus standalone listing dominate the discussion, with traders talking through the transition to Fox shares and bidding farewell to the ticker. Reactions are mixed: some accept the buyout and move on, while others criticize the deal as undervaluing Roku or regret losing its independent growth story.

Autonomi (ANT) is a cryptocurrency launched in 2025and operates on the Arbitrum platform. Autonomi has a current supply of 1,200,000,000 with 346,011,579 in circulation. The last known price of Autonomi is 0.02922544 USD and is up 6.14 over the last 24 hours. It is currently trading on 15 active market(s) with $124,611.31 traded over the last 24 hours. More information can be found at https://autonomi.com.

Aragon

Discussion is dominated by ticker confusion: many posts use ANT.X for Anthropics proposed IPO, debating its valuation and large AI-compute commitments, rather than Aragons crypto token. Aragon-specific posts are fragmented across its completed token-redemption/dissolution and DAO-governance updates, with no clear current catalyst established.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys QNX ecosystem is drawing attention, especially its Valeo smart-camera platform with design wins at Chinese automakers and its Nvidia and robotics connections. Traders are upbeat about the recent share-price strength and buying activity, while skeptics question whether partnerships and backlog will translate into meaningful revenue and see the stock as range-bound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$WULF Big money is aggressively loading at 22.33 after yesterday’s blockbuster announcement. A 20-year lease with AI titan Anthropic locking in a massive $19B in contracted revenue completely changes the valuation game. By transitioning volatile crypto mining rewards into highly predictable AI/HPC cloud infrastructure revenue, institutional risk profiles are completely flipped. Monestising the Abernathy JV stake for $530M also drops massive cash to the balance sheet for wholly owned assets, entirely bypassing dilutive capital raises. The technical structure just printed a huge volume reversal right off the multi-day wash-out floor.

Stock

Pick

Jwa68

Dylan

StockTwits For Android 

Christopher

StockTwits Web

TeraWulf Inc

A stronger-than-expected quarterly report and Googles credit support for financing tied to TeraWulfs Anthropic data-center lease have fueled optimism, with a new construction agreement adding to the buildout narrative. Bulls see the developments as reducing financing risk, while skeptics cite losses, debt, execution risks and weakness across AI data-center stocks; the reaction has been volatile.

 Big money is aggressively loading at 22.33 after yesterday’s blockbuster announcement. A 20-year lease with AI titan Anthropic locking in a massive $19B in contracted revenue completely changes the valuation game. By transitioning volatile crypto mining rewards into highly predictable AI/HPC cloud infrastructure revenue, institutional risk profiles are completely flipped. Monestising the Abernathy JV stake for $530M also drops massive cash to the balance sheet for wholly owned assets, entirely bypassing dilutive capital raises. The technical structure just printed a huge volume reversal right off the multi-day wash-out floor.